1285575-04-3

Upstream product

• 3964-57-6 methyl 4-hydroxy-3-chlorobenzoate 

Downstream Products

• 1092309-17-5 methyl 3-chloro-5-iodo-4-methoxybenzoate 
• 1285572-89-5 3-(3-chloro-4-hydroxy-5-methylsulfanylbenzoyl)-1,1-dioxo-1,2-dihydro-3H-1,3-benzothiazole 
• 1092308-38-7 3-chloro-5-iodo-4-methoxybenzoic acid 
• 1092309-13-1 3-chloro-5-iodo-4-methoxybenzoyl chloride 
• 1285575-08-7 3-(3-chloro-5-iodo-4-methoxybenzoyl)-2,3-dihydro-1,3-benzothiazole 
• 1285575-10-1 3-(3-chloro-5-iodo-4-methoxybenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole 
• 1285575-12-3 3-(3-chloro-4-hydroxy-5-iodobenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole 
• 1285575-14-5 3-(3-chloro-4-methoxy-5-methylsulfanylbenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole 
• 1285572-92-0 3-(3-chloro-4-hydroxy-5-methylsulfonylbenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole 
• 1285575-15-6 3-(3-chloro-4-methoxy-5-methylsulfonylbenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole 
• 1285572-93-1 3-(3-chloro-4-hydroxy-5-methylsulfinylbenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole 
• 1608147-89-2 methyl 3-chloro-5-iodo-4-[(propan-2-yl)oxy]benzoate 

Relevant academic research and scientific papers

1,3,4-OXADIAZOLONE COMPOUND AND MEDICINE

The purpose of the present invention is to provide a compound having PIM inhibitory activity. Examples of the present invention include 1,3,4-oxadiazolone compounds represented by the following formula [1], and pharmaceutically acceptable salts, and solvates thereof. The compounds of the present invention have PIM inhibitory activity. In addition, since the compounds of the present invention have PIM inhibitory activity, the compounds of the present invention are useful as therapeutic agents for systemic lupus erythematosus, lupus nephritis, etc.

ORGANIC COMPOUNDS

Novel benzofuran derivatives are disclosed. The derivatives have S1P1 receptor activity and/or disease modifying activity and find use in the treatment of conditions or diseases associated with the immune, vascular and nervous systems in animals and/or humans

NOVEL PHENOL DERIVATIVE

Disclosed are a novel compound and a pharmaceutical product, each having a remarkable uricosuric effect. Specifically disclosed are: a novel phenol derivative represented by general formula (1) that is shown in FIG. 1; a pharmaceutically acceptable salt t